BCTX · BriaCell Therapeutics Corp.
$3.64
+0.19 (+5.51%)
At close · Aug 7
Going-concern doubt
— flagged Jun 9, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The uncertainty of the Company’s ability to raise such financial capital casts substantial doubt on the Company’s ability to continue as a going concern.”View the 10-Q filed Jun 9, 2026
Market Cap
$30.01M
Shares
8.70M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Marc Lustig | board of directors | Resigned | 2024-11-25 |